➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Express Scripts
Moodys
Baxter
Boehringer Ingelheim

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

NORDITROPIN Drug Profile


Email this page to a colleague

« Back to Dashboard

Recent Clinical Trials for NORDITROPIN

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Tongji HospitalPhase 2/Phase 3
Xiamen Amoytop Biotech Co., Ltd.Phase 2/Phase 3
Center for Human ReproductionPhase 1/Phase 2

See all NORDITROPIN clinical trials

Recent Litigation for NORDITROPIN

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
SMITH v. NOVO NORDISK INC.2016-08-08

See all NORDITROPIN litigation

PTAB Litigation
PetitionerDate
2017-05-19

See all NORDITROPIN litigation

Company Disclosures: US Patents for NORDITROPIN

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 001 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2014-05-06 RX company
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 001 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2016-07-05 RX company
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 002 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2014-05-06 RX company
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 002 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2016-07-05 RX company
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 003 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2014-05-06 RX company
Novo Nordisk Inc NORDITROPIN somatropin INJECTABLE;INJECTION 021148 003 2001-03-30   Get Started Free Novo Nordisk A/S (Bagsvaerd, DK) 2016-07-05 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for NORDITROPIN

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Baxter
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.